Product Information
DILTIAZEM 24H ER(CD) 240 MG CP is a generic product labeled by Endo USA Inc., priced at $0.1969 per EA under NDC 10370083105. Its NADAC has been published 491 times since May 10, 2017.
FDA first approved this application on Dec 20, 1999. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
240 mg/1
Manufacturer
Endo USA Inc.NDC
10370083105
Classification
Generic
Dosage Form
CAPSULE, COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074984FDA Approved
12/20/1999
TE Code
AB3
On Market Since
10/1/2015
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 24H ER(CD) 240 MG CP has been published 491 times since May 10, 2017, and over the history we have for it it has declined 62.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1969 per EA |
|---|---|
| All-time high | $0.5271 (May 10, 2017) |
| All-time low | $0.1900 (May 20, 2026) |
| 52-week high | $0.2162 |
| 52-week low | $0.1900 |
| Median price | $0.2990 |
| Average price | $0.2858 |
| Largest weekly change | +34.5% (Jun 19, 2024) |
| Weeks tracked | 491 |
| Tracking since | May 10, 2017 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Endo USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diltiazem Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 24H ER(CD) 240 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(CD) 240 MG CP, manufactured by Endo USA Inc., is $0.1969 per EA (NDC 10370083105), effective Sep 30, 2026.
How has the price of DILTIAZEM 24H ER(CD) 240 MG CP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 24H ER(CD) 240 MG CP has declined 62.7%. It has been tracked across 491 weekly CMS publications since May 10, 2017.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(CD) 240 MG CP?
Since May 10, 2017, the NADAC for DILTIAZEM 24H ER(CD) 240 MG CP has ranged from a low of $0.1900 (May 20, 2026) to a high of $0.5271 (May 10, 2017), with a median of $0.2990 per EA.
Are there cheaper alternatives to DILTIAZEM 24H ER(CD) 240 MG CP?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24HR ER 240 MG CAP, is $0.1482 per EA — about 25% below DILTIAZEM 24H ER(CD) 240 MG CP.
Who manufactures DILTIAZEM 24H ER(CD) 240 MG CP?
DILTIAZEM 24H ER(CD) 240 MG CP (NDC 10370083105) is labeled by Endo USA Inc., and CMS classifies it as a generic product.